Published in Hum Vaccin on November 21, 2008
Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin. Vaccine (2009) 1.16
Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice. Hum Vaccin Immunother (2015) 0.80
Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol (2005) 7.88
Highly efficient DNA synthesis by the phage phi 29 DNA polymerase. Symmetrical mode of DNA replication. J Biol Chem (1989) 7.18
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet (2006) 5.72
Fidelity of phi 29 DNA polymerase. Comparison between protein-primed initiation and DNA polymerization. J Biol Chem (1993) 5.42
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol (1999) 5.21
Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol (2002) 4.87
The annual production cycle for influenza vaccine. Vaccine (2003) 3.10
Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther (2003) 2.95
Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol (2000) 2.84
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis (2007) 2.36
TempliPhi, phi29 DNA polymerase based rolling circle amplification of templates for DNA sequencing. Biotechniques (2002) 2.00
Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther (2004) 1.90
DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Infect Dis (2002) 1.88
Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol (1989) 1.85
The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. Antiviral Res (2000) 1.81
Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine (2000) 1.63
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine (2005) 1.59
DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol (1999) 1.57
Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir Ther (2007) 1.52
Immunogenicity of novel consensus-based DNA vaccines against avian influenza. Vaccine (2007) 1.52
Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine (2000) 1.35
DNA vaccines: recent developments and future possibilities. Hum Gene Ther (2006) 1.33
H5N1 viruses and vaccines. PLoS Pathog (2007) 1.30
Promoters and control elements: designing expression cassettes for gene therapy. Curr Gene Ther (2004) 1.30
A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA. Mol Ther (2001) 1.28
Neuraminidase inhibitor resistance in influenza viruses. J Med Virol (2007) 1.28
Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology (2008) 1.23
Pathogenesis of and immunity to avian influenza A H5 viruses. Biomed Pharmacother (2000) 1.23
Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Hum Vaccin (2007) 1.23
Avian and pandemic influenza: an overview. Vaccine (2007) 1.12
Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition. J Virol (1993) 1.11
Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. Biochem Biophys Res Commun (2006) 1.10
Neurological manifestations of avian influenza viruses in mammals. Avian Dis (2003) 1.06
CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses. J Immunol (2000) 1.05
Mechanisms of pathogenicity of influenza A (H5N1) viruses in mice. Avian Dis (2003) 0.99
Cell-based protein vaccines for influenza. Curr Opin Mol Ther (2005) 0.97
Inhibitory effect of lipopolysaccharide on immune response after DNA immunization is route dependent. DNA Cell Biol (1998) 0.88
CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination. Immunology (2005) 0.88
Introduction to DNA vaccines issue. Vaccine (2006) 0.85
DNA immunisation with minimalistic expression constructs. Vaccine (2004) 0.85
Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery. Vaccine (2007) 0.83
A simple method for the production of plasmid DNA in bioreactors. Methods Mol Med (2006) 0.81
CpG: the double-edged sword. Hum Gene Ther (1999) 0.79
Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challenge. Hum Gene Ther (2007) 0.77
A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis (2011) 3.91
IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol (2004) 3.84
The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J Virol (2006) 2.22
Molecular ecology techniques for the study of aerobic methanotrophs. Appl Environ Microbiol (2007) 2.13
Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity (2012) 2.13
Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett (2005) 2.13
Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation. Proc Natl Acad Sci U S A (2006) 2.07
Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway. J Immunol (2005) 2.03
Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells. J Virol (2005) 2.00
A viral RNA structural element alters host recognition of nonself RNA. Science (2014) 1.71
Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice. Vaccine (2007) 1.58
Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J Virol (2005) 1.53
Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. Am J Respir Cell Mol Biol (2008) 1.29
Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology (2008) 1.23
Marine methylotrophs revealed by stable-isotope probing, multiple displacement amplification and metagenomics. Environ Microbiol (2008) 1.22
Encephalitic alphaviruses. Vet Microbiol (2009) 1.21
Mice lacking alpha/beta and gamma interferon receptors are susceptible to junin virus infection. J Virol (2010) 1.20
Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin. Vaccine (2009) 1.16
Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology (2007) 1.16
Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrob Agents Chemother (2005) 1.15
Application of a loop-mediated isothermal amplification method for the detection of pathogenic Leptospira. Diagn Microbiol Infect Dis (2008) 1.14
Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A (2014) 1.13
Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic venezuelan equine encephalitis virus. J Virol (2005) 1.13
Are individual differences in fatigue vulnerability related to baseline differences in cortical activation? Behav Neurosci (2005) 1.11
Differential regulation of MUC5AC/Muc5ac and hCLCA-1/mGob-5 expression in airway epithelium. Am J Respir Cell Mol Biol (2005) 1.10
Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. Am J Trop Med Hyg (2008) 1.10
Junín virus pathogenesis and virus replication. Viruses (2012) 1.07
Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J Virol (2010) 1.06
Junín virus infection activates the type I interferon pathway in a RIG-I-dependent manner. PLoS Negl Trop Dis (2012) 1.05
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion. PLoS Pathog (2013) 1.05
Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome. Neuro Oncol (2012) 1.05
Functional interferon system is required for clearance of lassa virus. J Virol (2012) 1.05
Environmental distribution and abundance of the facultative methanotroph Methylocella. ISME J (2010) 1.04
Bcl-2 protein in 518A2 melanoma cells in vivo and in vitro. Clin Cancer Res (2006) 1.04
A proteomic approach identifies proteins in hepatocytes that bind nascent apolipoprotein B. J Biol Chem (2002) 1.03
PMA stimulates MUC5B gene expression through an Sp1-based mechanism in airway epithelial cells. Am J Respir Cell Mol Biol (2007) 1.01
Experimental Everglades virus infection of cotton rats (Sigmodon hispidus). Emerg Infect Dis (2004) 1.00
Identity of active methanotrophs in landfill cover soil as revealed by DNA-stable isotope probing. FEMS Microbiol Ecol (2007) 1.00
Three-year follow-up of secondary anterior iris fixation of an aphakic intraocular lens to correct aphakia. J Cataract Refract Surg (2012) 0.99
Trimethylamine N-oxide metabolism by abundant marine heterotrophic bacteria. Proc Natl Acad Sci U S A (2014) 0.99
Venezuelan equine encephalitis virus infection of spiny rats. Emerg Infect Dis (2005) 0.98
Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses. J Mol Biol (2013) 0.98
Paeoniflorin induced immune tolerance of mesenteric lymph node lymphocytes via enhancing beta 2-adrenergic receptor desensitization in rats with adjuvant arthritis. Int Immunopharmacol (2007) 0.98
Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins. Virology (2007) 0.97
ORFeome-based search of airway epithelial cell-specific novel human [beta]-defensin genes. Am J Respir Cell Mol Biol (2003) 0.97
Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers. Virology (2008) 0.96
Origin and characteristics of internal genes affect infectivity of the novel avian-origin influenza A (H7N9) virus. PLoS One (2013) 0.95
Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus. Clin Vaccine Immunol (2013) 0.95
Recombinant alphaviruses are safe and useful serological diagnostic tools. Am J Trop Med Hyg (2007) 0.95
Pseudomonas aeruginosa pyocyanin causes airway goblet cell hyperplasia and metaplasia and mucus hypersecretion by inactivating the transcriptional factor FoxA2. Cell Microbiol (2011) 0.95
Treatment of hepatocellular carcinoma with adeno-associated virus encoding interleukin-15 superagonist. Hum Gene Ther (2010) 0.95
NF-κB mediates IL-1β- and IL-17A-induced MUC5B expression in airway epithelial cells. Am J Respir Cell Mol Biol (2010) 0.95
CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells. J Virol (2013) 0.93
Vγ4+ T cells regulate host immune response to West Nile virus infection. FEMS Immunol Med Microbiol (2011) 0.92
CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus. Vaccine (2009) 0.92
Root exudates modify bacterial diversity of phenanthrene degraders in PAH-polluted soil but not phenanthrene degradation rates. Environ Microbiol (2010) 0.92
Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei. BMC Immunol (2008) 0.91
Rapid, non-invasive imaging of alphaviral brain infection: reducing animal numbers and morbidity to identify efficacy of potential vaccines and antivirals. Vaccine (2011) 0.91
TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs. Vaccine (2010) 0.91
Chemical characteristic and anticoagulant activity of the sulfated polysaccharide isolated from Monostroma latissimum (Chlorophyta). Int J Biol Macromol (2008) 0.91
Regulation of Cigarette Smoke (CS)-Induced Autophagy by Nrf2. PLoS One (2013) 0.90
A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery. Int J Oncol (2011) 0.88
Recombinant multiepitope protein for diagnosis of leptospirosis. Clin Vaccine Immunol (2008) 0.88
Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine. Vaccine (2011) 0.88
Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (αβ/γ) receptor double knockout mice. J Virol (2013) 0.88
A culture-independent approach to unravel uncultured bacteria and functional genes in a complex microbial community. PLoS One (2012) 0.87
Dual-source CT coronary angiography without heart rate or rhythm control in comparison with conventional coronary angiography. Int J Cardiovasc Imaging (2009) 0.87
Identification of Nrf2-dependent airway epithelial adaptive response to proinflammatory oxidant-hypochlorous acid challenge by transcription profiling. Am J Physiol Lung Cell Mol Physiol (2007) 0.87
DNA enzyme generated by a novel single-stranded DNA expression vector inhibits expression of the essential bacterial cell division gene ftsZ. Biochemistry (2004) 0.87
Negative control of TLR3 signaling by TICAM1 down-regulation. Am J Respir Cell Mol Biol (2011) 0.87
Diversity and activity of methanotrophs in alkaline soil from a Chinese coal mine. FEMS Microbiol Ecol (2009) 0.87
Comparative stability studies of poly(2-methyl-2-oxazoline) and poly(ethylene glycol) brush coatings. Biointerphases (2012) 0.86
Cloning and characterization of human MUC19 gene. Am J Respir Cell Mol Biol (2010) 0.86
Intra-abdominal administration of bevacizumab diminishes intra-peritoneal adhesions. Am J Surg (2010) 0.85
Antiproliferative activity of G-quartet-containing oligonucleotides generated by a novel single-stranded DNA expression system. Cancer Gene Ther (2003) 0.85